Serum ceruloplasmin as a diagnostic marker of cancer
- 23 December 1997
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 121 (2) , 139-145
- https://doi.org/10.1016/s0304-3835(97)00340-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Utility of plasmatic levels of alpha-1-antiprotease (A1AP) as a cancer markerCancer Letters, 1995
- Serum Ceruloplasmin, Plasma Copper Concentration and Copper to Ceruloplasmin Ratio in Cervical CarcinomaGynecologic and Obstetric Investigation, 1993
- Acute phase reactant proteins—an aid to monitoring surgical treatment of laryngeal carcinomaThe Journal of Laryngology & Otology, 1992
- Ceruloplasmin gene expression in human cancer cellsLife Sciences, 1987
- Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule.Proceedings of the National Academy of Sciences, 1984
- Specific receptor for ceruloplasmin in membrane fragments from aortic and heart tissuesBiochemistry, 1984
- Serum copper and ceruloplasmin levels in rheumatoid arthritis and degenerative joint disease and their pharmacological implicationsPharmacological Research Communications, 1983
- Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed ratsBritish Journal of Pharmacology, 1983
- Serum copper and related variables in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1978
- Clinical Significance of the Blood Copper in Hodgkin’s DiseaseActa Haematologica, 1960